CN1054528C - Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" - Google Patents
Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" Download PDFInfo
- Publication number
- CN1054528C CN1054528C CN96101580A CN96101580A CN1054528C CN 1054528 C CN1054528 C CN 1054528C CN 96101580 A CN96101580 A CN 96101580A CN 96101580 A CN96101580 A CN 96101580A CN 1054528 C CN1054528 C CN 1054528C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese patent
- medicine
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese patent medicine for treating psoriasis. The treatment effect of all the existing Chinese patent medicine for treating psoriasis needs to be further improved. For the present invention, an oral Chinese patent medicine is prepared from twenty-one raw traditional Chinese medicines of glabrous greenbrier rhizome, buffalo horn, pangolin, fleeceflower root, liquorice, flavescent sophora root, etc. The prescription is simple and clear. The present invention is suitable for various types and all the pathogenic stages of psoriasis. The clinical effective rate can reach 96.7%, and the long-term half-year consolidating rate can reach 90%; moreover, the toxic and side effects are small, and the safety and the reliability are high.
Description
The invention belongs to the psoriatic Chinese patent medicine of a kind of treatment.
Psoriasis also claims psoriasis, and traditional Chinese medical science bits " white arrange " are a kind of chronic dermatosis of common easy recurrence.Doctor trained in Western medicine does not still have specific drug at present to the treatment of primary disease, and generally with vitamin and antitumor drug treatment, uncertain therapeutic efficacy is cut and is difficult to and consolidates, and the traditional Chinese medical science also has some to treat this sick medicine, but all remains further to be improved its curative effect.
The present invention aims to provide a kind of good effect, the psoriatic Chinese patent medicine of the treatment that toxic and side effects is little.
The technical scheme that realizes above-mentioned purpose is: this Chinese patent medicine is to adopt following Chinese medicine raw materials by weight proportion to make:
Rhizoma Smilacis Glabrae 25-35 part Indigo Naturalis 8-12 part Calculus Bovis 5-7 part Cornu Bubali 17-23 part
Radix Scrophulariae 13-17 part Radix Paeoniae Rubra 16-20 part Radix Polygoni Multiflori 13-17 part Squama Manis 17-23 part
Hirudo 6-10 part Stigma Croci 4-6 part Zaocys 25-35 part
Periostracum Serpentis 8-12 part Scorpio 13-17 part Scolopendra 5-7 bar Cortex Dictamni 17-23 part
Radix Sophorae Flavescentis 13-17 part Radix Pseudostellariae 10-14 part
Rhizoma Atractylodis Macrocephalae 13-17 part Radix Clematidis 14-18 Nidus Vespae 8-12 part Radix Glycyrrhizae 4-8 part
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine
The traditional Chinese medical science thinks that psoriasis is because heresy of wind and cold, wind heat, rheumatism is outer attacks, and causes battalion to defend and becomes estranged, and the internal injury caused by excess of seven emotions eating and drinking without temperance, and taste are become estranged, due to the qi and blood stagnation, with wind, heat, wet, tremble with fear, heat in blood, blood are dry, blood stasis and deficiency of the liver and kindey etc. are relevant.It is considered herein that wind, heat, the stasis of blood, dryly be main paathogenic factor, thus with heat-clearing and toxic substances removing, promoting blood circulation and cooling blood, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription is main prescription foundation.Rhizoma Smilacis Glabrae, Indigo Naturalis, Calculus Bovis, Stigma Croci, Radix Scrophulariae, Zaocys are the product of heat-clearing and toxic substances removing, expelling wind and removing dampness in the side; Cornu Bubali, Radix Paeoniae Rubra have the merit of clearing away heat and cooling blood; Squama Manis, Hirudo, Scorpio, Scolopendra blood circulation and removing stasis, endogenous wind stopping are moisturized; Radix Polygoni Multiflori, Radix Pseudostellariae, the Rhizoma Atractylodis Macrocephalae, the Radix Glycyrrhizae skin moistening that nourishes blood, air making-up and spleen enlivening; Radix Sophorae Flavescentis, Periostracum Serpentis, Cortex Dictamni removing damp to relieve itching; Nidus Vespae, Radix Clematidis expelling wind and removing dampness, full side's compatibility not only takes stopgap measures but also effect a permanent cure.
Routine psoriatic all obtained satisfactory effect surplus this Chinese patent medicine was used for the treatment of 3000, was to the clinical efficacy statistical analysis of 60 routine patient's medications after 90 days below
After three courses of treatment (90 days), total effective rate is 96.7%, and wherein to ordinary and joint type curative effect the best, effective percentage all reaches 100%.In addition, also carried out late result observation, in the effective case of 58 examples of treatment, observation efficacy consolidation half a year is recidivist's 52 examples not, the rate of consolidation is 90%, 6 routine symptoms is only arranged to some extent repeatedly, promptly obtains improvement 1-2 the course of treatment but continue medication, confirm this medicine to psoriasis satisfactory effect not only, and efficacy consolidation.
The model case king builds thread, man, people from Lanzhou, workman
First visit on October 28 in 92 year, the patient claims to suffer from psoriasis more than 9 years, once uses the Chinese and western drugs multi-treatment all invalid, existing erythra dispersed whole body is speckle shape and ring-type, and base coat colour is dim red, the thicker dry squama of last shoe silver gray, clear border, it is not obvious to peel off the back basilar hemorrhage, heavy, indigestion and loss of appetite when light during pruritus, the loose stool, tongue is dim red, ecchymosis is arranged, deep-slow pulse, card belongs to the dry stasis of blood poison of blood.Oral Chinese patent medicine kangyinlin capsule every day of giving that the present invention makes three times, each 6.The further consultation after January of taking medicine, the attenuation of patient's skin rash, pruritus takes a turn for the better, and appetite is promoted, and symptom takes a favorable turn, and takes medicine two months again, and in further consultation on January 29 in 1994, erythra was all eliminated on one's body, and it is normal that skin recovers, and clinical recovery is followed up a case by regular visits to and is recurred half a year again.
This medicine all with the product of the comparatively gentle safety of the property of medicine, is not all found any toxic and side effects through using thousands of examples.
The principles of formulating prescriptions of " heat-clearing and toxic substances removing, promoting blood circulation and cooling blood, dispelling wind for relieving itching, nourshing Yin and drynsessmoistening prescription " of the present invention meet psoriatic occurrence regularity, are the principal elements that obtains desirable curative effect.Simultaneously, psoriasis is in different onset stage clinical manifestation difference, the common basis of differential diagnosis in tcm not consubstantiality card is divided into heat in blood, blood is dry, blood stasis, dialectical the executing of types such as wind and cold controlled, the present invention has then caught wind, heat, the stasis of blood, dry four kinds of main diseases because of, again in conjunction with the characteristics of skin lesion, method with treating both the principal and secondary aspects of a disease, only adopt simple and clear pharmaceutical formulation, promptly caught the principal contradiction of disease, be applicable to psoriatic different differentiation of symptoms and signs for classification of syndrome and each morbidity stage, effective percentage can reach 96.7%, curative effect height and late result are satisfied, consolidate rate long term and reach 90%, toxic and side effects is little simultaneously, low price.
Embodiment 1 present embodiment adopts following Chinese medicinal raw materials
20 parts of 6 parts of Cornu Bubalis of 10 parts of Calculus Boviss of 30 parts of Indigo Naturaliss of Rhizoma Smilacis Glabrae
20 parts of 18 parts of Radixs Polygoni Multiflori of 15 parts of Radix Paeoniae Rubra of Radix Scrophulariae, 15 powder Squama Maniss
10 parts of 30 parts of Periostracum Serpentiss of 5 parts of Zaocyss of 8 parts of Stigma Crocis of Hirudo
15 parts of 20 parts of Radix Sophorae Flavescentiss of 6 Cortex Dictamni of 15 parts of Scolopendras of Scorpio
10 parts in 16 parts of Nidus Vespae of 15 parts of Radix Clematidis of 12 parts of Rhizoma Atractylodis Macrocephalaes of Radix Pseudostellariae
6 parts in Radix Glycyrrhizae
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation;
Method for making: above-mentioned raw material of Chinese medicine is chosen decontamination, oven dry, pulverization, the 0.5 gram capsule of packing into.
Usage: the each clothes of adult 6-8 grain, every day 2-3 time, eliminating cold for resuscitation water send down, and child's consumption cuts down according to the circumstance, contraindication in pregnancy.
The course of treatment: continuous use one month was a course of treatment, and for consolidating curative effect, three courses of treatment of logotype are a treatment stage.
Embodiment 2 present embodiments adopt following Chinese medicinal raw materials
17 parts of 5 parts of Cornu Bubalis of 8 parts of Calculus Boviss of 25 parts of Indigo Naturaliss of Rhizoma Smilacis Glabrae
23 parts of 17 parts of Squama Maniss of 20 parts of Radixs Polygoni Multiflori of 17 parts of Radix Paeoniae Rubra of Radix Scrophulariae
8 parts of 25 parts of Periostracum Serpentiss of 4 parts of Zaocyss of 6 parts of Stigma Crocis of Hirudo
17 parts of 23 parts of Radix Sophorae Flavescentiss of 7 Cortex Dictamni of 17 parts of Scolopendras of Scorpio
8 parts in 14 parts of Nidus Vespae of 13 parts of Radix Clematidis of 10 parts of Rhizoma Atractylodis Macrocephalaes of Radix Pseudostellariae
8 parts in Radix Glycyrrhizae
Above-mentioned Chinese medicine raw materials by weight proportion is chosen decontamination, and pulverization adds proper honey by " Chinese Pharmacopoeia " medicine pill processing method and makes honeyed pill, every ball 9 grams, the each clothes of adult one ball, every day 2-3 time.
Embodiment 3 present embodiments adopt following Chinese medicinal raw materials
23 parts of 7 parts of Cornu Bubalis of 12 parts of Calculus Boviss of 35 parts of Indigo Naturaliss of Rhizoma Smilacis Glabrae
17 parts of 13 parts of Squama Maniss of 16 parts of Radixs Polygoni Multiflori of 13 parts of Radix Paeoniae Rubra of Radix Scrophulariae
12 parts of 35 parts of Periostracum Serpentiss of 6 parts of Zaocyss of 10 parts of Stigma Crocis of Hirudo
13 parts of 17 parts of Radix Sophorae Flavescentiss of 5 Cortex Dictamni of 13 parts of Scolopendras of Scorpio
12 parts in 18 parts of Nidus Vespae of 17 parts of Radix Clematidis of 14 parts of Rhizoma Atractylodis Macrocephalaes of Radix Pseudostellariae
4 parts in Radix Glycyrrhizae
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Claims (2)
1; treat psoriatic Chinese patent medicine; it is characterized in that this medicine adopts following Chinese medicinal raw materials Rhizoma Smilacis Glabrae 25-35 part Indigo Naturalis 8-12 part Calculus Bovis 5-7 part Cornu Bubali 17-23 part Radix Scrophulariae 13-17 part Radix Paeoniae Rubra 16-20 part Radix Polygoni Multiflori 13-17 part Squama Manis 17-23 part Hirudo 6-10 part Stigma Croci 4-6 part Zaocys 25-35 part Periostracum Serpentis 8-12 part Scorpio 13-17 part Scolopendra 5-7 bar Cortex Dictamni 17-23 part Radix Sophorae Flavescentis 13-17 part Radix Pseudostellariae 10-14 part Rhizoma Atractylodis Macrocephalae 13-17 part Radix Clematidis 14-18 part Nidus Vespae 8-12 part Radix Glycyrrhizae 4-8 part that above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
2, Chinese patent medicine according to claim 1 is characterized in that, this medicine adopts following Chinese medicinal raw materials
20 parts of 6 parts of Cornu Bubalis of 10 parts of Calculus Boviss of 30 parts of Indigo Naturaliss of Rhizoma Smilacis Glabrae
20 parts of 15 parts of Squama Maniss of 18 parts of Radixs Polygoni Multiflori of 15 parts of Radix Paeoniae Rubra of Radix Scrophulariae
10 parts of 30 parts of Periostracum Serpentiss of 5 parts of Zaocyss of 8 parts of Stigma Crocis of Hirudo
15 parts of 20 parts of Radix Sophorae Flavescentiss of 6 Cortex Dictamni of 15 parts of Scolopendras of Scorpio
10 parts in 16 parts of Nidus Vespae of 15 parts of Radix Clematidis of 12 parts of Rhizoma Atractylodis Macrocephalaes of Radix Pseudostellariae
6 parts in Radix Glycyrrhizae
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96101580A CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN96101580A CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1134837A CN1134837A (en) | 1996-11-06 |
CN1054528C true CN1054528C (en) | 2000-07-19 |
Family
ID=5117128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN96101580A Expired - Fee Related CN1054528C (en) | 1996-03-26 | 1996-03-26 | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1054528C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755502A (en) * | 2012-08-06 | 2012-10-31 | 廖丽萍 | External use washing liquor for relieving psoriasis |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1060375C (en) * | 1997-04-08 | 2001-01-10 | 刘文江 | Traditional Chinese medicinal preparation for curing psoriasis |
CN1089594C (en) * | 1997-12-10 | 2002-08-28 | 叶章照 | Traditional Chinese medicine for curing psoriasis |
CN1073433C (en) * | 1998-12-06 | 2001-10-24 | 牛余森 | Medicine for psoriasis and preparing method thereof |
WO2003086434A1 (en) * | 2002-04-15 | 2003-10-23 | Tetsuo Santo | Drinking tea for treating dermatitis |
CN101279054B (en) * | 2008-05-22 | 2010-12-22 | 陈三元 | Chinese medicinal composition for treating psoriasis |
CN102847004B (en) * | 2012-08-31 | 2013-11-06 | 霍山县中医院 | Traditional Chinese medicine for treating psoriasis by using cornu bubali |
CN102961652B (en) * | 2012-11-28 | 2015-04-08 | 马保华 | Chinese medicinal composition for treating psoriasis and application thereof |
CN104000906A (en) * | 2014-06-12 | 2014-08-27 | 济南科纳信息科技有限公司 | Traditional Chinese medicine composition for treating psoriasis |
-
1996
- 1996-03-26 CN CN96101580A patent/CN1054528C/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
《北京中医学院学报》1992年第15卷第6期 1992.6.30 金起凤,消银解毒汤治疗银屑病血热型108例疗效观察 * |
《北京中医学院学报》1992年第15卷第6期 1992.6.30 金起凤,消银解毒汤治疗银屑病血热型108例疗效观察;《浙江中医杂志》1986年第21卷第7期 1986.7.31 司在和,银花解毒汤为主治疗银屑病100例 * |
《浙江中医杂志》1986年第21卷第7期 1986.7.31 司在和,银花解毒汤为主治疗银屑病100例 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755502A (en) * | 2012-08-06 | 2012-10-31 | 廖丽萍 | External use washing liquor for relieving psoriasis |
CN102755502B (en) * | 2012-08-06 | 2013-12-25 | 廖丽萍 | External use washing liquor for relieving psoriasis |
Also Published As
Publication number | Publication date |
---|---|
CN1134837A (en) | 1996-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1872180A (en) | Medication of membranous milk vetch for activating blood and the channels, and preparation method | |
CN1054528C (en) | Already prepared traditional Chinese medicine for treating psoriasis named "kangyinlin" | |
CN101214365B (en) | Chinese medicine composing prescription for treating mastoproliferation | |
CN1840160A (en) | Powder for resisting hyperosteogeny | |
CN1137404A (en) | Drug for curing pulmonary tuberculosis | |
CN1404854A (en) | Medicine for treating nosal inflammation | |
CN1099980A (en) | Chinese-medicinal capsule for treatment of psoriasis | |
CN1134298A (en) | "Dianxianningxiwan" pills-Chinese patent medicine for epilepsy | |
CN1895593A (en) | Medicine for treating acne and its preparation | |
CN1631430A (en) | Chinese medicinal ointment for treating bone diseases | |
CN1312085A (en) | Dermatosis treating medicine | |
CN1089594C (en) | Traditional Chinese medicine for curing psoriasis | |
CN113769033A (en) | Mongolian medicine prescription for treating hernial disease | |
CN1698735A (en) | Medicine for treating psoriasis | |
CN1242806C (en) | Medicine | |
CN1296830A (en) | Chinese-medicinal capsule for treating diabetes | |
CN1879722A (en) | A medicine for treating rheumatic arthritis | |
CN1233408C (en) | Tablet medicine for treating pharyngolaryngitis and its preparation method | |
CN117959394B (en) | Use of Shenqi Tongmai preparation in preparing medicine for preventing and treating diabetic neuropathy | |
CN1076622C (en) | Chinese medicine for curing nephritis | |
CN101167915B (en) | Traditional Chinese medicine for treating chronic superficial gastritis and its preparation method | |
CN1057925C (en) | Pill for treating hepatitis and ascites due to liven cirrhosis, and method for preparing same | |
CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
CN1094355C (en) | Yugan pill for curing hepatitis and ascites due to cirrhosis | |
CN1060656C (en) | Yuganwan pill-medicine for hepatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |